Arcutis Biotherapeutics, Inc. (ARQT)Healthcare | Biotechnology | Westlake Village, United States | NasdaqGS
24.53 USD
+0.34
(1.406%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 24.07 -0.46 (-0.460%) ⇩ (April 17, 2026, 7:31 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 4:20 p.m. EDT
ARQT appears to be in a state of uncertainty with mixed signals from options activity and recent news. While there are some positive developments, such as analyst upgrades and phase 3 data announcements, insider selling and a negative earnings outlook suggest caution. The stock is trading near its 52-week low, but recent price movements show some resilience. For short-term traders, the options data suggests potential for both upward and downward momentum, making it a high-risk opportunity. For long-term investors, the fundamentals are weak, and the lack of dividends makes it unsuitable for income-focused strategies. Overall, the stock is not a strong buy at this time. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.078815 |
| MSTL | 0.078894 |
| AutoTheta | 0.103838 |
| AutoARIMA | 0.164341 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 25.87 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.495 |
| Excess Kurtosis | -0.86 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 60.439 |
| Revenue per Share | 2.956 |
| Market Cap | 3,042,539,008 |
| Forward P/E | 19.19 |
| Beta | 1.77 |
| Profit Margins | -4.29% |
| Website | https://www.arcutis.com |
As of April 11, 2026, 4:20 p.m. EDT: Options activity indicates mixed signals. Calls show increased positioning on the upside, with notable interest in strikes above the current price, suggesting potential bullish sentiment. However, puts also show significant activity, especially on the downside, indicating caution or bearish expectations. The high implied volatility and open interest in both calls and puts suggest uncertainty and potential for sharp price movements. The overall options landscape reflects a balance between bullish and bearish speculation.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.8130082 |
| Address1 | 3,027 Townsgate Road |
| Address2 | Suite 300 |
| All Time High | 40.88 |
| All Time Low | 1.76 |
| Ask | 24.84 |
| Ask Size | 9 |
| Audit Risk | 2 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 1,032,780 |
| Average Daily Volume3 Month | 1,308,777 |
| Average Volume | 1,308,777 |
| Average Volume10Days | 1,032,780 |
| Beta | 1.767 |
| Bid | 24.17 |
| Bid Size | 9 |
| Board Risk | 6 |
| Book Value | 1.536 |
| City | Westlake Village |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 24.53 |
| Current Ratio | 3.167 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 24.8 |
| Day Low | 24.235 |
| Debt To Equity | 60.439 |
| Display Name | Arcutis Biotherapeutics |
| Earnings Call Timestamp End | 1,778,099,400 |
| Earnings Call Timestamp Start | 1,778,099,400 |
| Earnings Timestamp | 1,778,097,600 |
| Earnings Timestamp End | 1,778,097,600 |
| Earnings Timestamp Start | 1,778,097,600 |
| Ebitda | -7,560,000 |
| Ebitda Margins | -0.0201 |
| Enterprise To Ebitda | -388.37 |
| Enterprise To Revenue | 7.807 |
| Enterprise Value | 2,936,075,776 |
| Eps Current Year | 0.37571 |
| Eps Forward | 1.27857 |
| Eps Trailing Twelve Months | -0.13 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 24.541 |
| Fifty Day Average Change | -0.01099968 |
| Fifty Day Average Change Percent | -0.00044821642 |
| Fifty Two Week Change Percent | 81.30082 |
| Fifty Two Week High | 31.77 |
| Fifty Two Week High Change | -7.24 |
| Fifty Two Week High Change Percent | -0.22788793 |
| Fifty Two Week Low | 12.42 |
| Fifty Two Week Low Change | 12.110001 |
| Fifty Two Week Low Change Percent | 0.9750403 |
| Fifty Two Week Range | 12.42 - 31.77 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,580,481,000,000 |
| Float Shares | 91,909,976 |
| Forward Eps | 1.27857 |
| Forward P E | 19.185495 |
| Free Cashflow | -15,702,750 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 354 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.90242994 |
| Gross Profits | 339,376,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01688 |
| Held Percent Institutions | 1.0865899 |
| Implied Shares Outstanding | 124,033,382 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California. |
| Long Name | Arcutis Biotherapeutics, Inc. |
| Market | us_market |
| Market Cap | 3,042,539,008 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_549019944 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -16,141,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 3,045,019,528 |
| Number Of Analyst Opinions | 8 |
| Open | 24.76 |
| Operating Cashflow | -5,625,000 |
| Operating Margins | 0.14197999 |
| Overall Risk | 6 |
| Payout Ratio | 0.0 |
| Phone | 805 418 5006 |
| Post Market Change | -0.460001 |
| Post Market Change Percent | -1.8752588 |
| Post Market Price | 24.07 |
| Post Market Time | 1,776,468,695 |
| Previous Close | 24.19 |
| Price Eps Current Year | 65.28972 |
| Price Hint | 2 |
| Price To Book | 15.970053 |
| Price To Sales Trailing12 Months | 8.09031 |
| Profit Margins | -0.042919997 |
| Quick Ratio | 2.828 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | 0.34 |
| Regular Market Change Percent | 1.40554 |
| Regular Market Day High | 24.8 |
| Regular Market Day Low | 24.235 |
| Regular Market Day Range | 24.235 - 24.8 |
| Regular Market Open | 24.76 |
| Regular Market Previous Close | 24.19 |
| Regular Market Price | 24.53 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 1,055,770 |
| Return On Assets | -0.019550001 |
| Return On Equity | -0.093030006 |
| Revenue Growth | 0.815 |
| Revenue Per Share | 2.956 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 124,033,382 |
| Shares Percent Shares Out | 0.1355 |
| Shares Short | 16,801,149 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 15,292,517 |
| Short Name | Arcutis Biotherapeutics, Inc. |
| Short Percent Of Float | 0.16600001 |
| Short Ratio | 12.1 |
| Source Interval | 15 |
| State | CA |
| Symbol | ARQT |
| Target High Price | 36.0 |
| Target Low Price | 33.0 |
| Target Mean Price | 34.75 |
| Target Median Price | 35.0 |
| Total Cash | 220,982,000 |
| Total Cash Per Share | 1.782 |
| Total Debt | 114,519,000 |
| Total Revenue | 376,072,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.13 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 22.406675 |
| Two Hundred Day Average Change | 2.1233253 |
| Two Hundred Day Average Change Percent | 0.09476307 |
| Type Disp | Equity |
| Volume | 1,055,770 |
| Website | https://www.arcutis.com |
| Zip | 91,361 |